£56.00

LAP Lambert Academic Publishing Computaional Design and Evaluation of Antibacterial agents

Price data last checked 9 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£56 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days · 82 data points (no recent data)

Historical
Generating forecast…
£56.00 £53.20 £54.32 £55.44 £56.56 £57.68 £58.80 27 June 2026 17 July 2026 06 August 2026 26 August 2026 16 September 2026

Price Distribution

Price distribution over 82 days • 1 price levels

Days at Price
82 days 0 21 41 62 82 £56 Days at Price

Price Analysis

Most common price: £56 (82 days, 100.0%)

Price range: £56 - £56

Price levels: 1 different prices over 82 days

Description

Infectious disease remains as major health problem due to the rapid development of resistance to existing antibacterial drugs. The spread of resistance among Gram negative bacterial like Pseudomonas aeruginosa, increase the limitation in the in the availability of therapeutic. The purpose of this book is to present an update perspective upon the use of Quinoline-2-one derivative as antibacterial agents, as well as computational design and prediction the binding with target protein to enhancing their antibacterial efficacy, in order to highlight potential new solutions to cope with infections resulting from drug-resistance bacteria. The Quinoline-2-one derivatives that designed and synthesized in this study presented novel and promising antibacterial agents, which bind with target protein (DNA gyrase) and maintained the cleavage complex with DNA and being lethal to bacteria. Design and evaluation of antibacterial activity of Quinoline-2-one derivatives opening new directions in drug discovery process.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Synthesis and antimicrobial screening of hybrid molecules of quinoline
84% match

Synthesis and antimicrobial screening of hybrid molecules of quinoline

£41.00 14 Sep 2026
Computer Design of New Heterocyclic Molecules as Drug Precursors: New candidate drugs in the treatment of cancer and microbial infections using bioinformatics and biostatistics tools
83% match

Computer Design of New Heterocyclic Molecules as Drug Precursors: New candidate drugs in the treatment of cancer and microbial infections using bioinformatics and biostatistics tools

LAP Lambert Academic Publishing

£55.00 13 Aug 2026
Antimicrobials: New and Old Molecules in the Fight Against Multi-resistant Bacteria
83% match

Antimicrobials: New and Old Molecules in the Fight Against Multi-resistant Bacteria

Springer

£108.01 07 Aug 2026
Synthesis And Bioactivities Evaluation Of Quinazolones
82% match

Synthesis And Bioactivities Evaluation Of Quinazolones

LAP Lambert Academic Publishing

£59.00 14 Sep 2026
Synthesis and screening of isatin derivatives
82% match

Synthesis and screening of isatin derivatives

LAP Lambert Academic Publishing

£47.00 14 Sep 2026
Instrumental Analysis Of Certain Fluoroquinolones In Pharmaceuticals
81% match

Instrumental Analysis Of Certain Fluoroquinolones In Pharmaceuticals

LAP Lambert Academic Publishing

£57.32 14 Sep 2026
Quinolone Antibacterials: 127 (Handbook of Experimental Pharmacology, 127)
81% match

Quinolone Antibacterials: 127 (Handbook of Experimental Pharmacology, 127)

Springer

£77.37 12 Sep 2026
Synthesis & Biological Assessment of Novel Hetero-cyclic Compounds: Hetero-cycles as Potential Chemotherapeutic Agents
80% match

Synthesis & Biological Assessment of Novel Hetero-cyclic Compounds: Hetero-cycles as Potential Chemotherapeutic Agents

LAP Lambert Academic Publishing

£67.00 15 Sep 2026
Antibacterial Therapy: Achievements, Problems and Future Perspectives
80% match

Antibacterial Therapy: Achievements, Problems and Future Perspectives

Springer

£75.77 15 Sep 2026
Chemistry of Novel Condensed Quinolines
80% match

Chemistry of Novel Condensed Quinolines

LAP Lambert Academic Publishing

£60.00 14 Sep 2026
Antiviral Drugs - The Rational Design of Antiviral Agents: The Most Updated Crash Course from Beginner to Advanced Learn All the Functions and ... in 7 Days or Less (Pharmaceutical Science)
79% match

Antiviral Drugs - The Rational Design of Antiviral Agents: The Most Updated Crash Course from Beginner to Advanced Learn All the Functions and ... in 7 Days or Less (Pharmaceutical Science)

£114.00 14 Sep 2026
Chemistry and Biological Potential of Quinoline-Derived Heterocycles: Unveiling the synthesis and biological significance of quinoline heterocycles
79% match

Chemistry and Biological Potential of Quinoline-Derived Heterocycles: Unveiling the synthesis and biological significance of quinoline heterocycles

LAP Lambert Academic Publishing

£76.00 27 Aug 2026
Nano-Antimicrobials: Progress and Prospects
79% match

Nano-Antimicrobials: Progress and Prospects

Springer

£144.18 29 Aug 2026
Emerging Modalities in Mitigation of Antimicrobial Resistance
79% match

Emerging Modalities in Mitigation of Antimicrobial Resistance

Springer

£127.28 13 Sep 2026
Preclinical Evaluation of Antimicrobial Nanodrugs (Nanotechnology in the Life Sciences)
79% match

Preclinical Evaluation of Antimicrobial Nanodrugs (Nanotechnology in the Life Sciences)

Springer

£51.80 29 Aug 2026
New therapeutic compounds against tuberculosis: In silico design of new therapeutic compounds targeting biosynthetic pathway of Mycolic acid in M. tuberculosis
79% match

New therapeutic compounds against tuberculosis: In silico design of new therapeutic compounds targeting biosynthetic pathway of Mycolic acid in M. tuberculosis

LAP Lambert Academic Publishing

£68.00 21 Aug 2026
Microwave Synthesis & Biological Activity of New 4(3H)-Quinazolinones: Microwave Synthesis, Anticancer, Antihistaminic, Antiinflammatory and Antiulcer Activity of New Series of Quinazolinones
78% match

Microwave Synthesis & Biological Activity of New 4(3H)-Quinazolinones: Microwave Synthesis, Anticancer, Antihistaminic, Antiinflammatory and Antiulcer Activity of New Series of Quinazolinones

LAP Lambert Academic Publishing

£71.00 27 Aug 2026
PDFpred: Antimicrobial Drug Screening Tool
78% match

PDFpred: Antimicrobial Drug Screening Tool

LAP Lambert Academic Publishing

£55.00 14 Sep 2026
Klebsiella pneumoniae in Iraq: Their extended spectrum-?-lactamases and bacteriocins
78% match

Klebsiella pneumoniae in Iraq: Their extended spectrum-?-lactamases and bacteriocins

LAP Lambert Academic Publishing

£67.00 14 Sep 2026
Study the Catalytic Role of CYP by Quantum Molecular Dynamics
78% match

Study the Catalytic Role of CYP by Quantum Molecular Dynamics

LAP Lambert Academic Publishing

£52.00 16 Sep 2026
Biotechnological Applications of Quorum Sensing Inhibitors
78% match

Biotechnological Applications of Quorum Sensing Inhibitors

Springer

£107.85 08 Aug 2026
Drug susceptibilities and mechanisms in Salmonella typhimurium: Drug susceptibilities and mechanisms of drug resistance among Salmonella enterica serovar typhimurium
78% match

Drug susceptibilities and mechanisms in Salmonella typhimurium: Drug susceptibilities and mechanisms of drug resistance among Salmonella enterica serovar typhimurium

LAP Lambert Academic Publishing

£56.00 12 Sep 2026
Molecular characterisation of antibiotic-resistant bacteria from water
78% match

Molecular characterisation of antibiotic-resistant bacteria from water

LAP Lambert Academic Publishing

£59.00 14 Sep 2026
Polymyxin Antibiotics: From Laboratory Bench to Bedside: 1145 (Advances in Experimental Medicine and Biology, 1145)
78% match

Polymyxin Antibiotics: From Laboratory Bench to Bedside: 1145 (Advances in Experimental Medicine and Biology, 1145)

Springer

£71.80 05 Aug 2026